Techcyte has been named 2025 Infectious Disease Testing Solution of the Year by the BioTech Breakthrough Awards, a leading ...
- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics ...
DENVER, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Wall Street opens to a convergence of science, scale, and strategic consolidation. From spider silk making mainstream headlines to multibillion-dollar ...
FG1 builds on the legacy of the Planova™ series — the world’s first virus removal filter, introduced by Asahi Kasei in 1989 — which revolutionized safety in biopharmaceutical manufacturing. The new ...
This update covers the latest in health sector news, including Gilead's impending acquisition of Ouro Medicines, Oryon Cell ...
Providing cutting-edge biolab coworking, equipment access, and startup support to bio innovators and early-stage ventures from Alameda to the world. BADASS Labs empowers innovators to focus on ...
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of life itself, as researchers learn to build quantum behavior directly into ...
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results